a) Muscle wasting in cancer: the clinical & survial impact
b) Symptom generation and causes of death
in cancer cachexia
c) Defining patients with cancer cachexia using
weightloss & BMI
d) Trial challenges: dealing with poor compliance,
drop-outs & mortality
e) Recruitment strategies for cancer cachexia trials
f) Recruitment in academic centers in Europe
g) General moderated disucussion

a) Anabolic interventions
b) Targeting muscle wasting
c) Other approaches
d) Anti-inflammatory therapies
e) Appetite stimulants
f) Nutrition approaches
g) General moderated discussion